当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › CANCER AND METASTASIS REVIEWS杂志
CANCER AND METASTASIS REVIEWS
基本信息
期刊名称 CANCER AND METASTASIS REVIEWS
CANCER METAST REV
期刊ISSN 0167-7659
期刊官方网站 http://link.springer.com/journal/10555
是否OA
出版商 Springer Netherlands
出版周期 Quarterly
始发年份 1982
年文章数 56
最新影响因子 9.2(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 ONCOLOGY 肿瘤学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 5.75 2.427 1.455
Biochemistry, Genetics and Molecular Biology
Cancer Research
26 / 191 86%
Medicine
Oncology
28 / 321 91%
补充信息
自引率 1.20%
H-index 127
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0167-7659%5BISSN%5D
投稿指南
期刊投稿网址 http://www.editorialmanager.com/canc/default.aspx
收稿范围

Contemporary biomedical research is on the threshold of an era in which physiological and pathological processes can be analyzed in increasingly precise and mechanistic terms. The transformation of biology from a largely descriptive, phenomenological discipline to one in which the regulatory principles can be understood and manipulated with predictability brings a new dimension to the study of cancer and the search for effective therapeutic modalities for this disease. Cancer and Metastasis Reviews provides a forum for critical review and discussion of these challenging developments.

Each issue of Cancer and Metastasis Reviews is devoted to a particular theme or topic and will contain from five to seven different contributions. In addition, an introductory preface is included from an individual who is distinguished in the field to be covered. The topics and contributors are chosen by the Editor-in-Chief after consultation with various members of the Editorial Advisory Board. Special emphasis is placed on subjects which are of relevance to the molecular and cellular biology of cancer metastasis and tumor progression, as well as to the treatment of metastatic disease. Occasional issues will be devoted to an in-depth clinical and biological analysis of a particular type of cancer.

A major function of the journal is to review some of the more important and interesting recent developments in the biology and treatment of malignant disease, as well as to highlight new and promising directions, be they technological or conceptual. Contributors are encouraged to review their personal work and be speculative.

收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

Editors-in-Chief:

Kenneth V. Honn
Distinguished Professor of Pathology, Oncology and Chemistry
Wayne State University School of Medicine, Detroit, MI, USA

Avraham Raz
Paul Zuckerman Professor of Oncology and Pathology,
Barbara Ann Karmanos Cancer Institute
Wayne State University, School of Medicine, Detroit, MI, USA

Editorial Advisory Board:

Robin AndersonPeter MacCallum Cancer Center, Australia 
Menashe Bar-Eli, UTMD Anderson Cancer Center, USA 
Ann F. Chambers, London Health Sciences Center, Canada
Michael Cher, Wayne State University School of Medicine, USA
David ChereshUniversity of California, San Diego, USA 
Isaiah J. Fidler, UTMD Anderson Cancer Center, USA
Paul Fisher, Virginia Commonwealth, USA
Mary J.C. Hendrix, Children's Hospital of Chicago Research Center, USA 
Meenhard Herlyn, The Wistar Institute, USA 
Yusuf Hannun, Stony Brook University, USA
Mien-Chie Hung, University of Texas MD Anderson Cancer Center, USA
John T. Isaacs, The Johns Hopkins Oncology Center, USA 
Rakesh Kumar, Rajiv Gandhi Centre for Biotechnology, India
Lawrence J. Marnett, Vanderbilt University School of Medicine, USA 
Dipak PanigrahyHarvard Medical School, USA
Richard Phipps, University of Rochester Medical Center, USA
Kenneth J. Pienta, Johns Hopkins University, USA 
Charles Serhan, Harvard Medical School, USA
Bonnie Sloane, Wayne State University School of Medicine, USA 
Saburo Sone, Tokushima University School of Medicine, Japan 
Joszef Timar, Semmelweis University, Hungary 
Danny Welch, Kansas University Cancer Center, USA


Founding Editors: 
Isaiah J. Fidler
Garth L. Nicolson
George Poste


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug